Cytek Biosciences Aktie
WKN DE: A3CVW1 / ISIN: US23285D1090
06.06.2024 14:26:05
|
Cytek Biosciences Board Approves Share Repurchase Of Up To $50 Mln
(RTTNews) - Cell analysis solutions company Cytek Biosciences, Inc. (CTKB) announced Thursday that its Board of Directors has approved the repurchase of up to an aggregate of $50 million of its common stock, subject to compliance with applicable law.
The Company's common stock is listed on The Nasdaq Global Select Market under the symbol "CTKB". The repurchase program will continue until December 31, 2024 unless extended or shortened by the Board of Directors.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cytek Biosciences, Inc Registered Shsmehr Nachrichten
05.08.25 |
Ausblick: Cytek Biosciences, mit Zahlen zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Cytek Biosciences, Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Cytek Biosciences, Inc Registered Shs | 3,40 | 0,59% |
|